Multiomics News and Research

RSS

AI shows promise in predicting type 2 diabetes but faces hurdles for clinical use

Researchers have conducted a comprehensive review of AI-based models for predicting type 2 diabetes, revealing their potential for individualized risk assessment and preventative care. Despite promising results, the study calls for more extensive validation and collaboration between AI and medical experts for effective clinical application.

26 Oct 2023

How are SARS-CoV-2 variants outsmarting our immune system and vaccines?

Researchers use multiomics analysis to understand how SARS-CoV-2 variants, including Alpha, Delta, and Omicron, modulate the host's cellular responses and adapt to evade human immunity. The study highlights the potential for targeted therapies against both adaptive and innate immune responses.

25 Sep 2023

Largest-ever study looks into the genetics of random "round-the-clock" blood glucose levels

Groundbreaking research published today in Nature Genetics describes the largest-ever study into the genetics of random "round-the-clock" blood glucose levels.

8 Sep 2023

Biosciences: how nature is changing the future of drug discovery

In this new podcast, Bruker's Kate Stumpo talks with Enveda's Pelle Simpson on the opportunities of natural products in the field of multiomics.

From Bruker Life Sciences Mass Spectrometry 6 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

Databases, techniques for variant forecasting and early warning of emerging infectious diseases

The coronavirus disease 2019 (COVID-19) pandemic has dramatically increased the awareness of emerging infectious diseases.

17 Aug 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

Illumina Inc., a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of VUMC, today announced the five founding members of the Alliance for Genomic Discovery.

17 Aug 2023

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

Researchers discuss the mechanisms of triptans for the treatment of spontaneous migraine attacks by using transcriptomics and metabolomics.

3 Aug 2023

COST catalyzes collaborative research in transcriptomics for cardiovascular disease

The Action has not only catalyzed research in this area by bringing together almost 300 participants from across Europe and beyond, but it also catalyzed the careers of younger researchers and launched a Horizon 2020 project: COVIRNA.

2 Aug 2023

IU researchers present groundbreaking findings at Alzheimer's conference

Researchers from Indiana University School of Medicine had a large presence and leadership role at the 2023 Alzheimer's Association International Conference in Amsterdam, Netherlands, with involvement in more than 150 presentations at the four-day meeting.

18 Jul 2023

New heart cell atlas reveals detailed structure of the human heart

In a new study, published today (12 July) in Nature, researchers have produced the most detailed and comprehensive human Heart Cell Atlas to date, including the specialised tissue of the cardiac conduction system - where the heartbeat originates.

12 Jul 2023

Study unveils potential early detection algorithm for neurodegeneration in rare genetic disorder

Xeroderma pigmentosum (XP) is a rare and devastating genetic disorder characterised by an inability to repair skin damage caused by ultraviolet (UV) light.

11 Jun 2023

Novel computational platform can expand the pool of cancer immunotherapy targets

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.

17 May 2023

Specially designed capsule gives a fuller picture of normal digestion in healthy people

Using a specially designed capsule, researchers can now voyage through the digestive system, collecting new data about digestion and microorganisms.

10 May 2023

Novel amino acid compound treats nonalcoholic fatty liver disease in non-human primates

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates -; bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests.

10 Apr 2023

Using unsupervised machine learning algorithms to classify osteosarcoma

A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, "Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis."

20 Mar 2023

Beckman Coulter Life Sciences presenting at SLAS2023

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition.

From Beckman Coulter Life Sciences 16 Feb 2023

Multiomics News and Research

AI shows promise in predicting type 2 diabetes but faces hurdles for clinical use

How are SARS-CoV-2 variants outsmarting our immune system and vaccines?

Largest-ever study looks into the genetics of random "round-the-clock" blood glucose levels

Biosciences: how nature is changing the future of drug discovery

How is next-generation protein sequencing democratizing protein sequencing?

Databases, techniques for variant forecasting and early warning of emerging infectious diseases

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

COST catalyzes collaborative research in transcriptomics for cardiovascular disease

IU researchers present groundbreaking findings at Alzheimer's conference

New heart cell atlas reveals detailed structure of the human heart

Study unveils potential early detection algorithm for neurodegeneration in rare genetic disorder

Novel computational platform can expand the pool of cancer immunotherapy targets

Specially designed capsule gives a fuller picture of normal digestion in healthy people

Novel amino acid compound treats nonalcoholic fatty liver disease in non-human primates

Using unsupervised machine learning algorithms to classify osteosarcoma

Beckman Coulter Life Sciences presenting at SLAS2023

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Study uncovers a strong link between gut bacteria and development of Parkinson’s disease

Study uncovers molecular features responsible for the development, progression of metastatic breast cancer

Omics eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News